Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vyloo
New York, New York, United Statesvyloo.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Vyloo is a digital health technology company dedicated to improving patient access to clinical trials through an AI-driven matching platform. The company provides a user-friendly interface for patients and healthcare providers to search for and enroll in relevant clinical research studies across a wide range of therapeutic areas. By optimizing the recruitment process, Vyloo helps pharmaceutical companies and research institutions accelerate their development timelines and bring new therapies to market more efficiently. The platform simplifies complex trial protocols into accessible language, empowering patients to make informed decisions about their care options.
- Industry
- Biomedical IT and Biomedical Data Platforms
Beyond the preview
Go deeper on Vyloo.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vyloo.